An integrated care pathway improves quality of life in Primary Biliary Cirrhosis.

BACKGROUND Clinical management of the chronic autoimmune liver disease, Primary Biliary Cirrhosis (PBC) involves addressing the underlying liver disease and a range of symptoms independent of liver disease severity. We have formally explored how these two perspectives of chronic disease management can be combined into a clinic consultation and impact upon quality of life (QOL) in PBC. AIMS To develop and implement the first Integrated Care Pathway (ICP) for the management of liver disease progression and symptom management in PBC. METHODS Process mapping of current practice by a multidisciplinary group developed a flowchart of care from which the clinical record evolved. Symptom assessment is incorporated into the PBC ICP (QOL; PBC-40, autonomic symptoms; Orthostatic Grading Scale, daytime sleepiness; Epworth Sleepiness Scale). All patients were considered who attended clinic between July 2005 and June 2006. Symptom assessment was repeated after 1 year in those participating in the initial clinic cohort. RESULTS The PBC ICP was successfully introduced into our clinical environment with high levels of patient satisfaction. A total of 225 PBC patients attended over 12 months. Initial QOL assessments were in 195 (87%). Five patients died (3%). Repeat assessment 1 year later occurred in 149 subjects (149/190; 78%). All symptom domains improved after ICP implementation with significant improvements in those with moderate and severe symptoms in all PBC-40 symptom domains (P < 0.02). In those with severe fatigue (n = 38) symptom improvement was even more dramatic (P = 0.002). CONCLUSION ICP implementation delivers evidence-based care, leads to improvements in QOL coupled with high levels of patient satisfaction.

[1]  A. Jacoby,et al.  Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis , 2005, Gut.

[2]  J. Newton,et al.  Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence , 2006, Hepatology.

[3]  R. Bhopal,et al.  Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. , 1997, International journal of epidemiology.

[4]  D. Howel,et al.  Primary biliary cirrhosis once rare, now common in the United Kingdom? , 1999, Hepatology.

[5]  Y. Chrétien,et al.  Quality of life in patients with primary biliary cirrhosis , 2004, Hepatology.

[6]  P. Sandroni,et al.  Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures. , 2005, Mayo Clinic proceedings.

[7]  A. Harrison,et al.  Developing an integrated care pathway for the management of falls and syncope in older people—the Newcastle experience , 2002 .

[8]  David E. J. Jones,et al.  The true impact of fatigue in primary biliary cirrhosis: a population study. , 2002, Gastroenterology.

[9]  Westgate Road,et al.  Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis , 2006 .

[10]  David C. Jones,et al.  Primary Biliary Cirrhosis , 2004, Autoimmunity.

[11]  G. Guyatt,et al.  Cholestatic liver diseases and health-related quality of life , 2000, American Journal of Gastroenterology.

[12]  J. Newton,et al.  Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. , 2006, Journal of hepatology.

[13]  D. Jones,et al.  Primary biliary cirrhosis. , 1960, Journal of internal medicine.

[14]  M. Johns,et al.  Sleepiness in different situations measured by the Epworth Sleepiness Scale. , 1994, Sleep.

[15]  A. Tran,et al.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis , 2000, American Journal of Gastroenterology.

[16]  J. Newton,et al.  An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis , 2006, Alimentary pharmacology & therapeutics.

[17]  M. Kaplan,et al.  Modafinil for the treatment of fatigue in primary biliary cirrhosis. , 2005, Annals of internal medicine.

[18]  J. Newton,et al.  Osteoporosis in primary biliary cirrhosis revisited , 2001, Gut.

[19]  R. Bhopal,et al.  Primary biliary cirrhosis: epidemiology helping the clinician , 1996, BMJ.

[20]  J. Newton,et al.  A predictive model for fatigue and its etiologic associations in primary biliary cirrhosis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  Westgate Road,et al.  Autonomic Dysfunction in Primary Biliary Cirrhosis Correlates with Fatigue Severity. , 2007 .